Yushi Chikasawa

Yushi Chikasawa

Auto-generated profile, based on publicly available information

Yushi Chikasawa

Department of Laboratory Medicine Tokyo Medical University Tokyo Japan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2023 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
YCYushi Chikasawa
Yushi Chikasawa
KAKagehiro Amano
Kagehiro Amano
KSKeiko Shinozawa
Keiko Shinozawa
MBMasato Bingo
Masato Bingo
RMRyui Miyashita
Ryui Miyashita
EKEi Kinai
Ei Kinai

8 October 2023 in Haemophilia
Verified
Journal Article
Closed access
Azusa NagaoAzusa Nagao
Azusa Nagao
YCYushi Chikasawa
Yushi Chikasawa
ASAkihiro Sawada
Akihiro Sawada
TKTakeshi Kanematsu
Takeshi Kanematsu
NYNaoya Yamasaki
Naoya Yamasaki
AGADVANCE Japan Working Group
ADVANCE Japan Working Group

23 May 2024 in Haemophilia
Verified
Journal Article
Closed access
Azusa NagaoAzusa Nagao
Azusa Nagao
YCYushi Chikasawa
Yushi Chikasawa
YHYukio Hiroi
Yukio Hiroi
MIMasahiro Ieko
Masahiro Ieko

1 January 2013 in Kansenshogaku Zasshi
Verified
Journal Article
Open access
TMTakashi Muramatsu
Takashi Muramatsu
NYNaoki Yanagisawa
Naoki Yanagisawa
YCYushi Chikasawa
Yushi Chikasawa
ISIkuo Seita
Ikuo Seita
MYMihoko Yotsumoto
Mihoko Yotsumoto
MAMinoru Ando
Minoru Ando
The improved survival of subjects with human immunodeficiency virus (HIV) has been accompanied by an increased prevalence of chronic kidney disease (CKD). Epidemic of CKD among those with HIV has not yet been evaluated in multiple tertiary hospitals in Japan. A cross-sectional study was conducted in 2011 at Tokyo Metropolitan Komagome Hospital (TMKH) and Tokyo Medical University Hospital (TMUH). A total of 1482 HIV-infected subjects (1384 men, 98 female, mean age: 44.2 +/- 11.4 years old) were consecutively enrolled in the study. Random urine and blood samples were collected to study prevalence of CKD. CKD was diagnosed as a decrease in glomerular function and/or proteinuria and classified into 5 stages based on National Kidney Foundation guidelines. The estimated glomerular filtration rate based on serum creatinine was calculated using the 3-variable equation, constructed by the Japanese Society of Nephrology. Proteinuria was defined as > or = 1+ on urine dipstick examination. All electronic medical charts were reviewed to determine comorbidities, including hypertension and diabetes mellitus (DM). The proportion of subjects receiving tenofovir disoproxil fumarate (TDF) was investigated. Risk factors for CKD were determined using multivariate logistic regression analysis. The mean CD4 cell count was 487 +/- 216/microL and 80.5% had undetectable HIV-RNA level in the combined cohort. Of the 90.2% of subjects taking antiretroviral agents, 61.5% was using TDF. The prevalence of overall CKD and CKD > or = stage 3 was 12.9% and 6.7%, respectively, both of which were nearly 3-fold higher in the TMKH cohort (p < .0001). Mean age and proportional prevalent hypertension and DM were significantly higher in the TKMH cohort than in the TMUH cohort. Multivariate analysis showed significant CKD to be associated with age > or =50 years (odds ratio [OR], 2.81), hypertension (OR, 3.04), and DM (OR, 2.05). CKD prevalence was 12.9% among combined cohorts, but differed significantly between them. Differences in age distribution and the proportion of comorbidities, including hypertension and DM, are likely involved.

27 July 2014 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
YCYushi Chikasawa
Yushi Chikasawa
KSKeiko Shinozawa
Keiko Shinozawa
KAKagehiro Amano
Kagehiro Amano
KOKyoichi Ogata
Kyoichi Ogata
THTakeshi Hagiwara
Takeshi Hagiwara
KFKatsuyuki Fukutake
Katsuyuki Fukutake

10 April 2025 in Blood Vessels, Thrombosis & Hemostasis
Verified
Journal Article
Open access
TATakafumi Akimoto
Takafumi Akimoto
HIHiroshi Inaba
Hiroshi Inaba
SOSoichi Ogishima
Soichi Ogishima
KKKazuki Kumada
Kazuki Kumada
AMAyano Mitsuhashi
Ayano Mitsuhashi
EKEi Kinai
Ei Kinai
• Analysis of the Japanese genome database showed no firm association between VWF pathogenic variants and phenotypic expression. • Estimating VWD prevalence directly based on the variant allele frequencies risks overestimation.